HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 20, No 12, December 2016 – Medical Imaging Technology       » Climate Change Could Hurt Coffee, Help Banana Production       » Partnerships and Innovation: Shaping the Future of Healthcare in Asia Pacific       » Chugai's Novel Antibody Technologies Put Singapore at the Centre of Fight Against Disease       » NUS Scientists Discover the "Switch" that Makes Breast Cancer Cells Aggressive      
EYE on CHINA
BGI Health collaborates with Eastern Biotech & Life Sciences on non-invasive fetal Trisomy test for improving reproductive health in the Middle East
BGI Health, one of BGI's affiliates, established a partnership with Eastern Biotech & Life Sciences, a biotechnology company based in Dubai, on the project of introducing non-invasive fetal trisomy (NIFTY) test to the United Arab Emirates (UAE) and other Gulf Cooperation Council (GCC) countries in the Middle East.

Fetal chromosomal aneuploidy disease is one of the most common birth defects, the leading cause of death for infants during the first year of life, such as Trisomy 21 (Down Syndrome), Trisomy 13 (Patau Syndrome), and Trisomy 18 (Edwards Syndrome). It will place an intolerable economic burden and adverse affect on their family members. Unfortunately, there is no effective method to cure this disease, but the key is to prevent by prenatal testing.

NIFTY is a new paradigm that can detect cell-free fetal DNA in the maternal blood with an accuracy of 99.9% in the detection of Down's syndrome as early as in 12 weeks of pregnancy. This non-invasive prenatal test in the first trimester of pregnancy has huge advantages in its high accuracy and sensitivity without posing any risk to the fetus, which has been widely accepting by pregnant women.

Dr. Faruq Badiuddin, Chairman of Eastern Biotech & Life Sciences, said, “I believe that this product launch is just the start of a long association with BGI to bring many more cost-effective genetic diagnostic products to the region.”

“We are hoping to work with BGI in larger projects that involve other genetic disorders, especially cancer genetics, monogenic disorders, and thalassemia, which has a very high incidence in the region”, he continued.

Dr. Ying Liu, Marketing Director of BGI Asia-Pacific, said, “With the fast development of next-gen sequencing (NGS), genetic testing is now becoming more and more cost affordable and widely acceptable. We are so pleased to have a collaboration with Eastern Biotech on NIFTY test, which is truly believed to bring huge convenience to all the pregnant women in the Middle East to have a health baby. We are looking forward to having deep collaborations with Eastern Biotech and further benefit local people's healthcare.”

Click here for the complete issue.

NEWS CRUNCH  
news Accuron Technologies' MedTech Division Invests into AWAK Technologies
news Philips introduces PerformanceBridge suite of operational performance improvement software and services for radiology departments
news Give a Gift that Will Last a Lifetime this Holiday Season with Smile Train
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Lungs & Respiratory System
February:
Cancer Research, Treatment/Technology
March:
Traditional Chinese Medicines
April:
Eye Care/ Eye Health
May:
The Piece of Your Mind - Brain Health/Science
June:
Featuring Biotech Start-Ups/Companies
July:
Food Science & Technology
August:
Diabetics Technology
September:
No. 1 Killer - Heart Diseases, Diagnosis and Treatment
October:
Skin Diseases/Allergic Reactions
November:
Diseases threatening our Children
December:
Liver Health & Treatment/Technology
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2016 World Scientific Publishing Co Pte Ltd  •  Privacy Policy